Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001415889-25-021718
Filing Date
2025-08-14
Accepted
2025-08-14 08:14:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8474
2 JOINT FILING AGREEMENT ex-99-08142025_120849.htm EX-99.1 2453
  Complete submission text file 0001415889-25-021718.txt   12785
Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI China
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI China 862161632588
Zai Lab Ltd (Subject) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90351 | Film No.: 251214503
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)